Chromatin remodeling and cancer, part I: covalent histone modifications

被引:284
作者
Wang, Gang G.
Allis, C. David
Chi, Ping
机构
[1] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
关键词
D O I
10.1016/j.molmed.2007.07.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dynamic chromatin remodeling underlies many, if not all, DNA-templated biological processes, including gene transcription; DNA replication and repair; chromosome condensation; and segregation and apoptosis. Disruption of these processes has been linked to the development and progression of cancer. The mechanisms of dynamic chromatin remodeling include the use of covalent histone modifications, histone variants, ATP-dependent complexes and DNA methylation. Together, these mechanisms impart variation into the chromatin fiber, and this variation gives rise to an 'epigenetic landscape' that extends the biological output of DNA alone. Here, we review recent advances in chromatin remodeling, and pay particular attention to mechanisms that appear to be linked to human cancer. Where possible, we discuss the implications of these advances for disease management strategies.
引用
收藏
页码:363 / 372
页数:10
相关论文
共 77 条
[1]   Sterile 20 kinase phosphorylates histone H2B at serine 10 during hydrogen peroxide-induced apoptosis in S. cerevisiae [J].
Ahn, SH ;
Cheung, WL ;
Hsu, JY ;
Diaz, RL ;
Smith, MM ;
Allis, CD .
CELL, 2005, 120 (01) :25-36
[2]   Histone H2B deacetylation at lysine 11 is required for yeast apoptosis induced by phosphorylation of H2B at serine 10 [J].
Ahn, Sung-Hee ;
Diaz, Robert L. ;
Grunstein, Michael ;
Allis, C. David .
MOLECULAR CELL, 2006, 24 (02) :211-220
[3]   Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors [J].
Bassing, CH ;
Suh, H ;
Ferguson, DO ;
Chua, KF ;
Manis, J ;
Eckersdorff, M ;
Gleason, M ;
Bronson, R ;
Lee, C ;
Alt, FW .
CELL, 2003, 114 (03) :359-370
[4]   Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? [J].
Baylin, SB ;
Ohm, JE .
NATURE REVIEWS CANCER, 2006, 6 (02) :107-116
[5]   Acetylation inactivates the transcriptional repressor BCL6 [J].
Bereshchenko, OR ;
Gu, W ;
Dalla-Favera, R .
NATURE GENETICS, 2002, 32 (04) :606-613
[6]   Anticancer activities of histone deacetylase inhibitors [J].
Bolden, Jessica E. ;
Peart, Melissa J. ;
Johnstone, Ricky W. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (09) :769-784
[7]   Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions [J].
Bracken, AP ;
Dietrich, N ;
Pasini, D ;
Hansen, KH ;
Helin, K .
GENES & DEVELOPMENT, 2006, 20 (09) :1123-1136
[8]   Oncogene-induced senescence as an initial barrier in lymphoma development [J].
Braig, M ;
Lee, S ;
Loddenkemper, C ;
Rudolph, C ;
Peters, AHFM ;
Schlegelberger, B ;
Stein, H ;
Dörken, B ;
Jenuwein, T ;
Schmitt, CA .
NATURE, 2005, 436 (7051) :660-665
[9]   A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers [J].
Carter, Scott L. ;
Eklund, Aron C. ;
Kohane, Isaac S. ;
Harris, Lyndsay N. ;
Szallasi, Zoltan .
NATURE GENETICS, 2006, 38 (09) :1043-1048
[10]   H2AX haploinsufficiency modifies genomic stability and tumor susceptibility [J].
Celeste, A ;
Difilippantonio, S ;
Difilippantonio, MJ ;
Fernandez-Capetillo, O ;
Pilch, DR ;
Sedelnikova, OA ;
Eckhaus, M ;
Ried, T ;
Bonner, WM ;
Nussenzweig, A .
CELL, 2003, 114 (03) :371-383